DalsnaFinance

Verastem doses first patient in lung cancer trial for VS-7375

Markets Investing.com By Investing.com 22 Jul 2026 20:04 1 min read
Verastem doses first patient in lung cancer trial for VS-7375

Verastem doses first patient in lung cancer trial for VS-7375

Verastem doses first patient in lung cancer trial for VS-7375

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.